EP3426250
Meðhöndlun á sjúklingi með CYP3A4 hvarfefnislyfi sem er frábent fyrir samfarandi gjöf með sterkum CYP3A4 hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.5.2017EP published:
23.3.2022EP application number:
17897227.9
EP translation filed:
3.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
15.5.2037Expiry date:
15.5.2026Next due date:
31.5.2026
Title in English:
TREATING A PATIENT WITH A CYP3A4 SUBSTRATE DRUG CONTRAINDICATED FOR CONCOMITANT ADMINISTRATION WITH A STRONG CYP3A4 INHIBITORLanguage of the patent:
English
Timeline
Today
16.5.2017EP application
23.3.2022EP Publication
3.5.2022Translation submitted
15.6.2022Registration published
15.5.2026Expires
Owner
Name:
Bow River LLCAddress:
2012 Seadrift Drive, Corona Del Mar, California 92625, US
Inventor
Name:
SRINIVASAN, SundarAddress:
Corona del Mar, California 92625, US
Name:
CHOW, ChristinaAddress:
Seattle, WA 98112, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 31/502, A61K 31/4545, A61K 31/47, A61K 31/675, A61K 31/506, A61K 31/519, A61K 31/4178, A61K 31/44, A61K 31/05, A61K 31/496, A61K 31/4985, A61P 9/00, A61P 25/24, A61K 31/495, A61P 35/02, A61P 35/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.5.2022
Expires: 15.5.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.4.2023
Expires: 15.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.4.2024
Expires: 15.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.5.2025
Expires: 15.5.2026
Payer: Árnason Faktor ehf.